Peptides & Peptide Synthesis Products

Fmoc-Lys(Boc,Me)-OH

Fmoc-Lys(Boc,Me)-OH

$150.00
$150.00
Fmoc-Lys(Boc,Me)-OH, Catalog No: 47238
(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-6-[methyl-[(2-methylpropan-2-yl)oxycarbonyl]amino]hexanoic acid, CAS: 951695-85-5, MW: 482.57, Formula: C27H34N2O6
Catalog No: 47238
(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-6-[methyl-[(2-methylpropan-2-yl)oxycarbonyl]amino]hexanoic acid, CAS: 951695-85-5, MW: 482.57, Formula: C27H34N2O6

* Required Fields

Description

Details

(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-6-[methyl-[(2-methylpropan-2-yl)oxycarbonyl]amino]hexanoic acid
Additional Information

Additional Information

Catalog Number 47238
CAS 951695-85-5
M.W. 482.57
Formula C27H34N2O6
IUPAC Name (2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-6-[methyl-[(2-methylpropan-2-yl)oxycarbonyl]amino]hexanoic acid
Synonym No
Also Known As No
InChIKey JHMSFOFHTAYQLS-QHCPKHFHSA-N
InChI InChI=1S/C27H34N2O6/c1-27(2,3)35-26(33)29(4)16-10-9-15-23(24(30)31)28-25(32)34-17-22-20-13-7-5-11-18(20)19-12-6-8-14-21(19)22/h5-8,11-14,22-23H,9-10,15-17H2,1-4H3,(H,28,32)(H,30,31)/t23-/m0/s1
SMILES CC(C)(C)OC(=O)N(C)CCCC[C@@H](C(=O)O)NC(=O)OCC1C2=CC=CC=C2C3=CC=CC=C13
Cited Uses

Details

1. Pipkorn R et al, "A Peptide & Peptide Nucleic Acid Synthesis Technology for Transporter Molecules and Theranostics - The SPPS", International Journal of Medical Sciences, 11(7) pp.697-706 ().
2. Taha MS et al, "Subcellular Fractionation and Localization Studies Reveal a Direct Interaction of the Fragile X Mental Retardation Protein (FMRP) with Nucleolin", PLoS ONE, 9(3) pp.e91465 ().
3. Abbate V et al, "Manipulating the pH response of 2,3-diaminopropionic acid rich peptides to mediate highly effective gene silencing with low-toxicity", Journal of Controlled Release, 172(3) pp.929-938 (2013 Dec 28).
4. Wu J et al, "Scaffold Ranking and Positional Scanning Utilized in the Discovery of nAChR-Selective Compounds Suitable for Optimization Studies", Journal of medicinal chemistry, 56(24) pp.10103-10117 (2013 Dec 27).
5. Flook AM et al, "Effects of Amino Acids on Melanoma Targeting and Clearance Properties of Tc-99m-Labeled Arg-X-Asp-Conjugated ?-Melanocyte Stimulating Hormone Peptides", Journal of medicinal chemistry, 56(21) pp.10.1021/jm4012356 (2013 Nov 14).
6. Kenyon NJ et al, "Self-Assembling Nanoparticles Containing Dexamethasone as a Novel Therapy in Allergic Airways Inflammation", PLoS ONE, 8(10) pp.e77730 ().
7. Trevaskis JL et al, "Improved Glucose Control and Reduced Body Weight in Rodents with Dual Mechanism of Action Peptide Hybrids", PLoS ONE, 8(10) pp.e78154 ().
8. Guimaraes CP et al, "Site-specific C-terminal internal loop labeling of proteins using sortase-mediated reactions", Nature protocols, 8(9) pp.1787-1799 (2013 Sep).
9. Wang W et al, "Loss of Apelin Exacerbates Myocardial Infarction Adverse Remodeling and Ischemia-reperfusion Injury: Therapeutic Potential of Synthetic Apelin Analogues", Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2(4) pp.e000249 ().
10. Banerjee SR et al, "Effect of Chelators on the Pharmacokinetics of 99mTc-Labeled Imaging Agents for the Prostate-Specific Membrane Antigen (PSMA)", Journal of medicinal chemistry, 56(15) pp.6108-6121 (2013 Aug 8).
11. Lamoliatte F et al, "Targeted Identification of SUMOylation Sites in Human Proteins Using Affinity Enrichment and Paralog-specific Reporter Ions", Molecular & Cellular Proteomics : MCP, 12(9) pp.2536-2550 (2013 Sep).
12. Wissner RF et al, "Labeling Proteins with Fluorophore/Thioamide FRET Pairs by Combining Unnatural Amino Acid Mutagenesis and Native Chemical Ligation", Journal of the American Chemical Society, 135(17) pp.6529-6540 (2013 May 1).
13. Sur S et al, "Tuning supramolecular mechanics to guide neuron development", Biomaterials, 34(20) pp.4749-4757 (2013 Jul).
14. Gr├╝nberg J et al, "DOTA-Functionalized Polylysine: A High Number of DOTA Chelates Positively Influences the Biodistribution of Enzymatic Conjugated Anti-Tumor Antibody chCE7agl", PLoS ONE, 8(4) pp.e60350 ().
15. Qin S et al, "Functional Characterization of Ferret CCL20 and CCR6 and Identification of Chemotactic Inhibitors", Cytokine, 61(3) pp.924-932 (2013 Mar).
16. Shimko JC et al, "Preparing Semisynthetic and Fully Synthetic Histones H3 and H4 to Modify the Nucleosome Core", Methods in molecular biology (Clifton, N.J.), 981() pp.10.1007/978-1-62703-305-3_14 (2013).
17. Cristina Giannotti K et al, "A Lys49 Phospholipase A2, Isolated from Bothrops asper Snake Venom, Induces Lipid Droplet Formation in Macrophages Which Depends on Distinct Signaling Pathways and the C-Terminal Region", BioMed Research International, 2013() pp.807982 (2013).
18. Novoa A et al, "Variation of the net charge, lipophilicity and side chain flexibility in Dmt1-DALDA: effect on opioid activity and biodistribution", Journal of medicinal chemistry, 55(22) pp.9549-9561 (2012 Nov 26).
19. Chen PC et al, "DNA-Interactive Properties of Crotamine, a Cell-Penetrating Polypeptide and a Potential Drug Carrier", PLoS ONE, 7(11) pp.e48913 ().
20. Huang J et al, "Residue analysis of a CTL epitope of SARS-CoV spike protein by IFN-gamma production and bioinformatics prediction", BMC Immunology, 13() pp.50 ().
21. Wu X et al, "Synthesis and evaluation of a peptide targeted small molecular Gd-DOTA monoamide conjugate for MR molecular imaging of prostate cancer", Bioconjugate chemistry, 23(8) pp.1548-1556 (2012 Aug 15).
22. Kizzire K et al, "High-Affinity PEGylated Polyacridine Peptide Polyplexes Mediate Potent In Vivo Gene Expression", Gene therapy, 20(4) pp.407-416 (2013 Apr).
23. Webber MJ et al, "Controlled Release of Dexamethasone from Peptide Nanofiber Gels to Modulate Inflammatory Response", Biomaterials, 33(28) pp.6823-6832 (2012 Oct).
24. Tatsi A et al, "[111In-DOTA]Somatostatin-14 analogs as potential pansomatostatin-like radiotracers - first results of a preclinical study", EJNMMI Research, 2() pp.25 ().
25. Li Y et al, "Opioid glycopeptide analgesics derived from endogenous enkephalins and endorphins", Future Medicinal Chemistry, 4(2) pp.205-226 (2012 Feb).
Reviews
cr